Effects of propranolol on some activities of amphetamine. 1968

P Mantegazza, and K M Naimzada, and M Riva

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001833 Body Temperature Regulation The processes of heating and cooling that an organism uses to control its temperature. Heat Loss,Thermoregulation,Regulation, Body Temperature,Temperature Regulation, Body,Body Temperature Regulations,Heat Losses,Loss, Heat,Losses, Heat,Regulations, Body Temperature,Temperature Regulations, Body,Thermoregulations
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001066 Appetite Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS. Appetite Alterations,Alteration, Appetite,Alterations, Appetite,Appetite Alteration,Appetites
D001069 Appetite Regulation Physiologic mechanisms which regulate or control the appetite and food intake. Food Intake Regulation,Intake Regulation, Food,Regulation, Appetite,Regulation, Food Intake,Appetite Regulations,Food Intake Regulations,Intake Regulations, Food,Regulations, Appetite,Regulations, Food Intake

Related Publications

P Mantegazza, and K M Naimzada, and M Riva
August 1965, The Journal of pharmacy and pharmacology,
P Mantegazza, and K M Naimzada, and M Riva
March 1975, Minerva medica,
P Mantegazza, and K M Naimzada, and M Riva
January 1968, American heart journal,
P Mantegazza, and K M Naimzada, and M Riva
July 1977, The Journal of pharmacology and experimental therapeutics,
P Mantegazza, and K M Naimzada, and M Riva
January 1971, Psychopharmacologia,
P Mantegazza, and K M Naimzada, and M Riva
July 1964, Psychopharmacologia,
P Mantegazza, and K M Naimzada, and M Riva
June 1980, The Journal of the Acoustical Society of America,
P Mantegazza, and K M Naimzada, and M Riva
January 1970, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
P Mantegazza, and K M Naimzada, and M Riva
January 1970, Clinical pharmacology and therapeutics,
P Mantegazza, and K M Naimzada, and M Riva
August 1978, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!